Dong, Qing <br/><br/>
Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.  [electronic resource] 

 -  Neuroscience letters  03 2019 
 - 184-190 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7972 
<br/><br/><label>Standard No.: </label>10.1016/j.neulet.2018.12.041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--metabolism<br/>Amyloid beta-Protein Precursor--metabolism<br/>Animals<br/>Brain--drug effects<br/>Brain-Derived Neurotrophic Factor--drug effects<br/>Cognition--drug effects<br/>Disease Models, Animal<br/>Glucagon-Like Peptide 1--drug effects<br/>Mice<br/>Receptors, AMPA--drug effects<br/>Sitagliptin Phosphate--pharmacology